Fifth Lane Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Fifth Lane Capital’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,000	Closed	-$384K	–	275
2023 Q2	$384K	Buy	+10,000	New	+$257K	0.11%	79

Fifth Lane Capital's KDNY Position: Q3 2023 in Review

Fifth Lane Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 10,000 shares — an estimated $384K sold.

Fifth Lane Capital first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $384K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Fifth Lane Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fifth Lane Capital sold 10,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $384K.
Fifth Lane Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Fifth Lane Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $384K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Fifth Lane Capital's 13F filing for Q3 2023, filed 14 Nov 2023.